期刊文献+

前列腺特异抗原正常进展型前列腺癌的临床特点分析 被引量:2

原文传递
导出
摘要 目的探讨正常水平血清前列腺特异抗原(PSA)进展型前列腺癌的临床特点。方法回顾性分析12例血清PSA值为0—4ng/ml并确诊为前列腺癌患者的临床资料。患者年龄60—77岁,平均67.5岁。B型超声检查发现阳性5例,后经前列腺穿刺活组织检查确诊;5例经尿道前列腺电切术,术后病理确诊;2例骨扫描异常,后经前列腺穿刺活检确诊。结果T。期6例,L期3例,Te期1例,MIb期2例;Gleason评分:2~4分2例,5~7分3例,8-10分7例。随访11例,术后3、6、9个月内分别死亡7、10、11例。结论血清PSA水平为0~4ng/ml进展型前列腺癌症状相对较轻,多数肿瘤细胞分化低,病情进展快,转移早,预后差。
出处 《肿瘤研究与临床》 CAS 2012年第3期191-192,共2页 Cancer Research and Clinic
  • 相关文献

参考文献7

  • 1Lujan M,Paez A,Miravalles E. Prostate cancer detection is also relevant in low prostate specific antigen ranges[J].European Urology,2004.155-159.doi:10.1016/j.eururo.2003.09.017.
  • 2Punglia RS,D' Amico AV,Catalona WJ. Effect of verification bias on screening for prostate cancer by measurement of prostatespecific antigen[J].New England Journal of Medicine,2003.335-342.
  • 3林延双,梁建波,何大光,刘时才,苏依莱,韦华玉.血清PSA测定与前列腺癌病理组织学类型关系的研究[J].中国男科学杂志,2006,20(8):45-48. 被引量:4
  • 4Nishio R,Furuya Y,Nagakawa O. Metastatic prostate cancer with normal level of serum prostate-specific antigen[J].International Urology and Nephrology,2003,(2):189-192.doi:10.1023/B:UROL.0000020306.08275.49.
  • 5Bozeman CB,Carver BS,Caldito G. Prostate cancer in patients with an abnormal digital rectal examination and serum prostate specific antigen less than 4.0 ng/ml[J].Urology,2005.803-808.doi:10.1016/j.urology.2005.04.058.
  • 6赤倉功一郎,张灵,周吉海.对前列腺特异性抗原(PSA)的见解[J].日本医学介绍,2004,25(4):167-169. 被引量:6
  • 7Yamamoto T,Ito K,Ohi M. Diagnostic significance of digital rectal examination and transrectal ultrasonography in men with prostate-specific antigen levels of 4 NG/ML or less[J].Urology,2001,(6):994-998.doi:10.1016/S0090-4295(01)01409-1.

二级参考文献6

  • 1Oesterling JE.Tacobson SJ.Klee GG,et al.Free,Complexed and total serum prostate specific antigen:the establishment of appropriate reference ranges for their concentions and ratios.J Urol 1995; 154(3):1090-1095
  • 2Hudson MA,Bahnson RR,Catalona WJ.Clinical use of prostate specific antigen in patients with prostate cancer.J Urol 1989; 142(4):1011-1017
  • 3Ferro MA,Barnes I,Roberts JB,et al.Tumour markers in prostatic carcinoma:a comparison of prostate specific antigen with acid Phosphatase.Br J Urol 1987; 60(1):69-73
  • 4Pannek J,Rittenhouse HG,Chan DW,et al.The use of precent free prostate specific antigen for staging clinically localized prostate cancer.J Urol 1998; 159(4):1238-1242
  • 5Carter HB.Pearson JD.Metter EJ,et al.Longitudinal evaluation of prostate specific antigen levels in men with and without prostate diseases.JAMA 1992; 267(16):2215-2220
  • 6周利群,陈为民,那彦群,黄有媛,冯陶,郝金瑞,潘柏年,薛兆英,顾方六,郭应禄.良性前列腺增生患者血清PSA与年龄变化的关系[J].中华泌尿外科杂志,2002,23(5):293-295. 被引量:38

共引文献8

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部